Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2173 Views
-
Last post by frodo
-
- 0 Replies
- 9983 Views
-
Last post by NHE
-
- 2 Replies
- 1646 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1841 Views
-
Last post by Petr75
-
- 0 Replies
- 1219 Views
-
Last post by NHE
-
- 2 Replies
- 1870 Views
-
Last post by frodo
-
- 0 Replies
- 10805 Views
-
Last post by NHE
-
- 0 Replies
- 2510 Views
-
Last post by frodo
-
- 0 Replies
- 2656 Views
-
Last post by NHE